Microsatellite Instability Testing
The latest news on microsatellite instability testing.
Biocartis Nabs FDA 510(k) Clearance for Lynch Syndrome Screening Assay
The Idylla MSI Test identifies microsatellite instability in colorectal cancer tumors to aid in the identification of potential Lynch syndrome.
In new guidelines, an expert panel recommended IHC and PCR for certain cancer types and pointed out knowledge gaps supporting NGS in other settings.
Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug
The companies aim to develop the companion diagnostic for use with Henlius' investigational treatment for microsatellite instability-high solid tumors.
Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer
The assay is intended to detect
Dana Farber Team Applies PCR Method to ID Microsatellite Instability in Tumor-Derived Samples
Premium
The group aims to adapt the method, which detects poly-adenine tails, to monitor for minimal residual disease in late-stage colon cancer patients after surgery.